Scarica l'app Stockscreener
3.88
22.55%
-1.13
Dopo l'orario di chiusura:
3.97
0.09
+2.32%
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.62%
2.0287
|
2.2697 | 2.1492 | 2.7818 | 2.8216 |
| Operating Income/Loss |
10.62%
-2.0287
|
-2.2697 | -2.1765 | - | - |
| Income/Loss From Continuing Operations Before Tax |
11.28%
-1.9928
|
-2.2463 | -2.1492 | -2.7818 | -2.8216 |
| Income/Loss From Continuing Operations After Tax |
11.28%
-1.9928
|
-2.2463 | -2.1492 | -2.7818 | -2.8216 |
|
Net Income/Loss
|
11.28%
-1.9928
|
-2.2463 | -2.1492 | -2.7818 | -2.8216 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
36.59%
1.6258
|
1.1903 | 20.04 | 0.2556 | 16.36 |
| Diluted Average Shares |
36.59%
1.6258
|
1.1903 | 20.04 | 0.2556 | 16.36 |
| Basic Earnings Per Share |
34.92%
-1.23
|
-1.89 | -0.11 | -0.16 | -0.17 |
| Diluted Earnings Per Share |
34.92%
-1.23
|
-1.89 | -0.11 | -0.16 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):